{
  "docId": "019de070-14f8-7659-9020-5924af9296cd",
  "docSlug": "a0353e82ff2da767329aa025539c408b",
  "documentTitle": "Legend Biotech | IPO Presentation Deck | 42 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 42,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a hub-and-spoke style diagram to represent the company's three strategic pillars.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de070-14f8-7659-9020-5924af9296cd/5",
  "deckHref": "/decks/019de070-14f8-7659-9020-5924af9296cd",
  "deckJsonHref": "/decks/019de070-14f8-7659-9020-5924af9296cd.json",
  "deckAnchorHref": "/decks/019de070-14f8-7659-9020-5924af9296cd#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Legend Biotech at center with three pillars: Pipeline, Collaboration, Platform",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd7718e9-902f-4629-a735-0d69dd9c7912",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "list",
      "text": "Lead product candidate LCAR-B38M/JNJ-4528; Broad portfolio of earlier-stage autologous product candidates; Future pipeline includes AML, Lymphoma, Gastric Cancer, Ovarian Cancer, Infectious Disease",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2dd03dfe-ecd0-4103-a517-8e35e4362f53",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.65,
        "y": 0.4
      },
      "kind": "list",
      "text": "In-house antibody generation; Early clinical proof-of-concept; Large-scale manufacturing facilities; >650 employees worldwide",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a4514cc-46ec-481c-ad68-16e7a125a47d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.35,
        "y": 0.4
      },
      "kind": "list",
      "text": "Global collaboration with Janssen; $350M upfront; $110M milestone payments; $1,240M potential future milestones",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "94ac5aa1-9f81-45b2-9bd5-c4529e62596d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "RRMM: Relapsed and/or Refractory Multiple Myeloma; AML: acute myeloid leukemia; KOL: key opinion leaders",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9152e347-102d-420b-99b8-c4545ed0197b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "We Are A Fully Integrated Global Cellular Therapy Company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62b03c4f-1ccb-461d-9a24-3ee9f3e72723",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "5f43c4e7-c898-43f1-8a32-5aa5e1192365",
      "evidence": "list/bullet: Lead product candidate LCAR-B38M/JNJ-4528; Broad portfolio of earlier-stage autologous product candidates; Future pipeline includes AML, Lymphoma, Gastric Cancer, Ovarian Cancer, Infectious Disease",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 6,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "4532b142-e248-43a5-a216-5c594f618423",
      "evidence": "The company's mission is presented on pages 5-6",
      "position": 0,
      "objective": "Why is Legend Biotech's mission important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}